Clinical trial
Probiotic on Type 2 Diabetes and Chronic Obstruction Pulmonary Disease
NCT05492448
Study timeline
Study start (actual)2022-09-19Date precision: day
Registry last updated2026-02-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Chronic Obstructive Pulmonary Diseaseunresolved
Interventions
PlaceboDIETARY_SUPPLEMENT
L. salivarius AP-32 and L. reuteri GL-104DIETARY_SUPPLEMENT
L. reuteri GL-104DIETARY_SUPPLEMENT
Sponsors & collaborators
Glac Biotech Co., Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05492448 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.